Saturday 30 March 2019

Celgene pops after top proxy advisors recommend Bristol-Myers investors approve buyout

Institutional Shareholder Services recommends Bristol-Myers Squibb shareholders vote in favor of its bid to buy Celgene.

from Health and Science https://ift.tt/2FBvrvp
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)